Notification of regenerative medicine provision plan

This is a treatment method in which T lymphocytes, which have various functions necessary to attack cancer, are cultured outside the body, activated and proliferated, and then administered to the patient.

This is a treatment method in which dendritic cells, which are immune cells that act as the command center for immune responses, take up cancer antigens that serve as markers for cancer cells and then return them to the body.​

This is a treatment method that attacks cancer by extracting lymphocytes present in the patient's blood, proliferating and activating mainly helper T cells and killer T cells, and returning them to the body.

This is a treatment in which dendritic cells isolated from the patient's own blood are given the function of activating NKT cells and then administered intravenously.

This is a type of cancer immunotherapy that utilizes the function of one's own NKT cells (natural killer T cells). NKT cells are named after the fact that they have the properties of both "NK cells" and "T cells."

NK cells are a type of immune cell found in lymphocytes that have the innate ability to attack foreign substances. NK cells play an important role in early cancer treatment and defense against infectious diseases.